Original Query: ALL
Previous Study | Return to List | Next Study

Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. (REPARO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01756456
Recruitment Status : Completed
First Posted : December 27, 2012
Last Update Posted : February 7, 2017
Information provided by (Responsible Party):
Dompé Farmaceutici S.p.A

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Primary Completion Date : April 2015
  Study Completion Date : May 2016

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 February 1, 2018